ResearcherKansai Medical UniversityActive in the last 2 years

Hidetaka Miyazaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-7062-817X. Sources: OpenAlex.

Their work

Papers: 5
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 16

Papers, trials and grants by year

2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 5

Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy. Co-author DOI 10.1002/jhbp.70146 ↗
Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1016/j.gastha.2025.100779 ↗
Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal… Co-author DOI 10.1245/s10434-024-16361-y ↗
Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal … Co-author DOI 10.1016/j.pan.2024.06.001 ↗
Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib. Co-author DOI 10.1186/s40792-024-01975-x ↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

So Yamaki · 5 shared papers, 2024–2026 · strength 1.12
Sohei Satoi · 5 shared papers, 2024–2026 · strength 1.12
Daisuke Hashimoto · 5 shared papers, 2024–2026 · strength 1.12
Yuki Matsui · 3 shared papers, 2024–2026 · strength 0.72
Tsukasa Ikeura · 3 shared papers, 2024–2026 · strength 0.62
Masashi Kanai · 2 shared papers, 2025–2026 · strength 0.45
- Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779 ↗
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y ↗
Denys Tsybulskyi · 2 shared papers, 2024–2025 · strength 0.43
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y ↗
- Paper Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based … DOI 10.1186/s40792-024-01975-x ↗
Motonobu Maruo · 2 shared papers, 2024–2026 · strength 0.40
- Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779 ↗
- Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001 ↗
Takashi Ito · 2 shared papers, 2024–2026 · strength 0.40
- Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779 ↗
- Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001 ↗
Makoto Naganuma · 2 shared papers, 2024–2026 · strength 0.40
- Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779 ↗
- Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001 ↗
Koh Nakamaru · 2 shared papers, 2024–2026 · strength 0.40
- Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779 ↗
- Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001 ↗
Ayaka Takaori · 2 shared papers, 2024–2026 · strength 0.40
- Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779 ↗
- Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001 ↗
Hiroyuki Ishida · 1 shared paper, 2026 · strength 0.29
- Paper Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy. DOI 10.1002/jhbp.70146 ↗
Mitsugu Sekimoto · 1 shared paper, 2025 · strength 0.22
- Paper Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable… DOI 10.1245/s10434-024-16361-y ↗
Takumi Funo · 1 shared paper, 2024 · strength 0.21
- Paper Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based … DOI 10.1186/s40792-024-01975-x ↗
Makoto Takaoka · 1 shared paper, 2024 · strength 0.16
- Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.